Back
Genmab A/S Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
GMAB
Genmab A/S
Last Price:
$29.30
Seasonality Move:
12.84%
7 Day Trial
ALL ACCESS PASS
$
7
Genmab A/S Stock Forecast
-
Over the next 52 weeks, Genmab A/S has on average historically risen by 36.9% based on the past 15 years of stock performance.
-
Genmab A/S has risen higher in 9 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Genmab A/S Stock Undervalued?The current Genmab A/S [GMAB] share price is $29.29. The Score for GMAB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Genmab A/S Stock Go Up Next Year?
-
Over the next 52 weeks, Genmab A/S has on average historically risen by 36.9% based on the past 15 years of stock performance.
Genmab A/S Stock Rating
Sell
30
Genmab A/S (GMAB)
is a Sell
Is Genmab A/S overpriced?
-
Genmab A/S has risen higher in 9 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Genmab A/S Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com
52-Week Data
52-Week High:
35.43
52-Week Low:
17.24
Prediction Charts
Market Cap:
18B
Price in USD:
29.29
Volume:
2.1M
Beta:
0.70
Technical Analysis
SMA50:
32.15
SMA100:
31.49
SMA200:
27.24
52-Wk Change:
30.53%
Stock Predictions
-
Is Genmab A/S stock public?Yes, Genmab A/S is a publicly traded company.
-
What is the Genmab A/S stock quote today?The Genmab A/S stock price is 29.29 USD today.
-
How to buy Genmab A/S stock online?You can buy Genmab A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-2 | 32.66 | 33.27 | 33.37 | 32.66 |
| Feb-3 | 33.24 | 33.03 | 33.52 | 32.87 |
| Feb-4 | 32.45 | 31.90 | 32.56 | 31.42 |
| Feb-5 | 31.35 | 30.97 | 32.04 | 30.95 |
| Feb-6 | 30.94 | 30.90 | 31.31 | 30.75 |
| Feb-9 | 31.27 | 30.87 | 31.30 | 30.62 |
| Feb-10 | 30.87 | 30.60 | 31.00 | 30.59 |
| Feb-11 | 30.42 | 30.06 | 30.42 | 29.66 |
| Feb-12 | 30.05 | 29.59 | 30.17 | 29.47 |
| Feb-13 | 29.65 | 30.03 | 30.47 | 29.65 |
| Feb-17 | 30.70 | 30.00 | 31.41 | 29.54 |
| Feb-18 | 29.25 | 29.16 | 29.52 | 28.84 |
| Feb-19 | 28.29 | 28.90 | 29.02 | 28.06 |
| Feb-20 | 29.04 | 29.29 | 29.49 | 28.94 |
Genmab A/S Earnings
Genmab A/S Earnings Report: Per Share Genmab A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.
Genmab A/S Forecast Revenue Growth
Genmab A/S Stock Analysis: Historical quarterly revenues per share for Genmab A/S and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.86 per share, and an increase next year of $0.79 per share.
* Genmab A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.